This Biotech Fund Sold $8 Million, Yet Remains Bullish on Terns
A biotech fund reduced its Terns Pharmaceuticals position by about $8 million last quarter. Despite the sale, the the...
Learn various ways to earn money from your interests, turning your hobbies into profitable opportunities.
18,548 articlesA biotech fund reduced its Terns Pharmaceuticals position by about $8 million last quarter. Despite the sale, the the...
The Roundhill Magnificent Seven ETF (MAGS) now provides one-ticker exposure to seven mega-cap AI leaders. It uses equ...
Zillow has fallen hard, but the question for investors is whether a comeback is plausible. This guide breaks down the...
A sharp one-week move in a space stock can redefine risk and opportunity. This guide explains why rocket stock skyroc...
Oil prices hovered near $86 per barrel early today, with Brent as the benchmark. Markets weigh demand signals, supply...
Tesla’s foray into robotics and AI promises upside, but it also introduces new risks for shareholders. This guide bre...
Two early leaders in the electric air taxi race collide with a policy signal that could tilt the field. This analysis...
Grocery Outlet GO's Q4 2025 earnings transcript sheds light on margin discipline, expansion plans, and the path to 20...
When an EBT scam drained a Bridgeport mother's SNAP funds, two local business owners stepped in to replace her month ...
A groundbreaking collaboration could redefine how AI and space tech work together. This article examines what spacex'...
NVIDIA, under Jensen Huang, has built more than chips—it's crafted an AI compute ecosystem. This article explains why...
A Kalshi insider-trading probe sparks headlines about a captivating, hypothetical scenario: a mrbeast video editor fi...